# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 2


A statement or cover letter drawing attention to any features which are particular to the clinical trial, if required.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/3/part/A1/paragraph/2 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-3/part-A1/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.